190
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Reproductive component vaccine developments for contraceptive and non-contraceptive uses

, BSc PhD & , BSc PhD
Pages 1473-1482 | Published online: 15 Jun 2011

Bibliography

  • Colton FB. Steroids and “the pill”: early steroid research at Searle. Steroids 1992;57:624-30
  • Aitken RJ, Baker MA, Doncel GF, As the world grows: contraception in the 21st century. J Clin Invest 2008;118:1330-43
  • Amy J-J, Tripathi V. Contraception for women: an evidence based overview. BMJ 2009;339:b2895
  • Brannigan RE. Reproductive endocrinology: Hormonal male contraception – a goal finally realized? Nat Rev Urol 2009;6:409-10
  • Bitzer J. Contraceptive compliance: why is contraceptive failure still so frequent? Ther Umsch 2009;66:137-43
  • Forrest JD. Epidemiology of unintended pregnancy and contraceptive use. Am J Obstet Gynecol 1994;170:1485-9
  • Cooper DW, Larsen E. Immunocontraception of mammalian wildlife: ecological and immunogenetic issues. Reproduction 2006;132:821-8
  • Aitken RJ. Immunocontraceptive vaccines for human use. J Reprod Immunol 2002;57:273-87
  • Ferro VA, Mordini E. Peptide vaccines in immunocontraception. Curr Opin Mol Ther 2004;6:83-9
  • McLaughlin EA, Aitken RJ. Is there a role for immunocontraception? Mol Cell Endocrinol 2011;335:78-88
  • Delves PJ, Lund T, Roitt IM. Antifertility vaccines. Trends Immunol 2002;23:213-19
  • Talwar GP, Vyas HK, Purswani S, Gupta JC. Gonadotropin-releasing hormone/human chorionic gonadotropin beta based recombinant antibodies and vaccines. J. Reprod Immunol 2009;83:158-63
  • Talwar GP, Singh O, Pal R, A vaccine that prevents pregnancy in women. Proc Natl Acad Sci USA 1994;91:8532-6
  • Kathuria S, Sriraman R, Nath R, Efficacy of plant produced recombinant antibodies against HCG. Human Reprod 2002;17:2054-61
  • Saxena BB, Rathnam P. HCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine. US20050032171A1; 2005
  • Iversen PI. Combined approach to treatment of cancer with hCG vaccines. US6764680B2; 2004
  • Cole LA. Method for treating cancer and identifying novel anti-cancer compounds. US007708991B2; 2010
  • Talwar GP, Purswani S, Gupta JC. A novel vaccine composition inducing bioeffective immune response against human chorionic gonadotropin. Application No. 524/DEL/2009
  • Dunshea FR, Colantoni C, Howard K, Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance. J Anim Sci 2001;79:2524-35
  • Killian G, Kreefer TJ, Rhyan J, Observations on the use of GonaCon in captive female elk (Cervus elaphus). J Wild Dis 2009;45:184-8
  • Killian G, Miller L, Rhyan J, Doten H. Immunocontraception of florida feral swine with a single-dose GnRH vaccine. Am J Reprod Immunol 2006;55:378-84
  • Naz RK, Gupta SK, Gupta JC, Recent advances in contraceptive vaccine development: a mini review. Hum Reprod 2005;20:3271-83
  • Talwar GP, Diwan M, Dawar H, Counter GnRH vaccine. In: Rajalakshmi M, Griffin PD, editors, Male contraception present and future. New Age International, New Delhi; 1998. p. 309-18
  • Reeves JJ, Bertrand KP, Zhang Y. Chimeric contraceptive vaccines. US006013770A; 2000
  • Talwar GP, Gupta JC, Raina K. Recombinant anti-LHRH vaccines for control of sex hormones dependent pathologies in humans and for control of estrus in female mammals and improve meat quality in male animals, Application No. 768/DEL/2003
  • Meloen RH, Oonk HB. Peptide immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine. US007341349B2; 2008
  • Alving CR. Design and selection of vaccine adjuvants: animal models and human trials. Vaccine 2002;20:S56-64
  • Moudgal NR, Jeyakumar M, Krishnamurthy HN, Development of male contraceptive vaccine – a perspective. Hum Reprod Update 1997;3:335-46
  • Moyle WR. Methods for altering fertility. US007001597B1; 2006
  • Moudgal NR, Ravidranath N, Murthy GS, Long-term contraceptive efficacy of vaccine of ovine follicle stimulating hormone in male bonnet monkeys. J Reprod Fertil 1992;96:91-102
  • Abdennebi-Najar L. Interests and limits of immunocontraception. Gynecol Obstet Fertil 2003;31:774-7
  • Jolivet-Reynaud C, Faure G, Dalbon P, Antigenic peptides reacting with anti-ovary antibodies. US006602853B1; 2003
  • Timmerman P, Puijik WC, Sloostra JW, Binding compounds, immunogenic compounds and peptidomimetics. US007863239B2; 2011
  • Timmerman P, Puijk WC, Meloen RH. Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS technology. J Mol Recognit 2007;20:283-99
  • Ferro VA, Stimson WH. Fertility-disrupting potential of synthetic peptides derived from the beta subunit of follicle stimulating hormone. Am J Reprod Immunol 1998;40:187-97
  • Nixon B, Aitkin, RJ, McLaughlin EA. New insights into the molecular mechanisms of sperm-egg interaction. Cell Mol Life Sci 2007;64:1805-23
  • Paterson M, Wilson MR, Jennings ZA, Design and evaluation of a ZP3 peptide vaccine in a homolgous primate model. Mol Hum Reprod 1999;5:342-52
  • Delsink AK, van Alterna J, Grobler D, Implementing immunocontraception in free-ranging African elephants. J S Afr Vet Assoc 2007;78:25-30
  • Miller LA, Johns BE, Killian GJ. Immunocontraception of white-tailed deer using native and recombinant zona pellucida vaccines. Anim Reprod Sci 2000;63:187-95
  • Gupta SK, Gupta N, Suman P, Zona pellucida-based contraceptive vaccines for human and animal utility. J Reprod Immunol 2011;88:240-6
  • Thayer EC, Webster PJ. Human secreted protein, ZZP1. US00692436B2; 2005
  • Dunbar BS. Immunogenic epitopes of the human zona pellucida protein (ZP1). US006455041B1; 2002
  • Brown R, Mezel M, Pohajdak W, Warick CK. Methods to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant. US00RE37224E; 2001
  • Brown R, Pohajdak W, Horrocks J, McLaren L. Compositions and methods for reducing or preventing fertilization in fish and birds. US006790457B1; 2004
  • Herr JC, Coonrod SA, Wright P. Egg specific surface proteins. US0062988B2; 2005
  • Matzuk MM, Wang P. Ovary-specific genes and proteins. US007335737B2; 2008
  • Mancini RE, Andrada JA, Saracini, D, Immunological and testicular response in man sensitised with human testicular homogenate. J Clin Endocrinol Metab 1965;25:859-75
  • Chamley LW, Clarke GN. Antisperm antibodies and conception. Semin Immunopathol 2007;29:169-84
  • Sofikitis N, Giotitsas N, Tsounapi P, Hormonal regulation of spermatogenesis and spermiogenesis. J Steroid Mol Biol 2008;109:323-30
  • Jegou B, Le Magueresse B, Pineau C, Sharpe RM. Germ cells and post-natal development of testicular function: in vitro studies. Bull Assoc Anat (Nancy) 1991;75:33-8
  • O'Rand MG, Widgren EE, Sivashanmugam P, Reversible immunocontraception in male monkeys immunized with eppin. Science 2004;306:1189-90
  • Chen Z, He W, Yan P, Protein prime-peptide boost as a new strategy induced an Eppin dominant B-cell epitope specific immune response and suppressed fertility. Vaccine 2009;27:733-40
  • Sipila P, Jalkanen J, Huhtaniemi IT, Poutanen M. Novel epididymal proteins as targets for the development of post-testicular male contraception. Reproduction 2009;137:379-89
  • Naz RK. Development of genetically engineered human sperm immunocontraceptives. J Reprod Immunol 2009;83:145-50
  • Suri A. Sperm specific proteins: potential candidate molecules for fertility control. Reprod Biol Endocrinol 2004;2:10-16
  • Suri A. Family of sperm associated antigens: relevance in sperm-egg interaction and immunocontraception. Soc Reprod Fertil Suppl 2007;63:433-43
  • Xu B, Copolla M, Herr JC, Timko MP. Expression of recombinant human sperm-agglutinating mini-antibody in tobacco (Nicotiana tabacum L.). Soc Reprod Fert Suppl 2007;63:465-77
  • Inoue N, Ikawa M, Okabe M. Putative sperm fusion protein IZUMO and the role of N-glycosylation. Biochem Biophys Res Commun 2008;377:910-14
  • Naz RK. Immunocontraceptive effect of Izumo and enhancement by combination vaccination. Mol Reprod Dev 2008;75:336-44
  • Wang DG, Huang TH, Xie DD, An G. Investigation of recombinant mouse sperm protein IZUMO as a potential immunocontraceptive agent. Am J Reprod Immunol 2008;59:225-34
  • Wang M, Shi JL, Cheng GY, The antibody against a nuclear autogenic sperm protein can result in reproductive failure. Asian J Androl 2009;11:183-92
  • Hardy CM, Beaton S, Hinds LA. Immunocontraception in mice using repeated, multi-antigen peptides: immunisation with purified recombinant antigens. Mol Reprod Dev 2008;75:126-35
  • Kurth BE, Digilio L, Dnow P, Immunogenicity of a multi-component recombinant human acrosomal protein vaccine in female Macaca fascicularis. J Reprod Immunol 2008;77:126-41
  • Naz RK, Aleem A. Effect of immunising with six sperm peptide vaccines on fertility of female mice. Soc Reprod Fert Suppl 2007;63:455-64
  • Honggang L, Xiaofang D, Huangtao G, Chengliang X. Inhibition of human sperm function and mouse fertilisation in vitro by an antibody against cation channel of sperm1: the contraceptive potential of its transmembrane domains and pore region. Fertil Steril 2009;92:1141-6
  • Hildebrand MS, Avenarius MR, Fellous M, Genetic male infertility and mutation of CatSper ion channels. Eur J Hum Genet 2010;18:1178-84
  • Herr JC, Jayes F, Mandal A, Human sperm specific lysozyme-like proteins. US7125550B2; 2006
  • Hao Z, Herr JC, Jayes FL, Sperm specific proteins. US007094547B2; 2006
  • Klinefelter GR. Contraceptives based on SP22 and SP22 antibodies. US007754212B2; 2010
  • Cone RA, Whaley KJ. Topical application of antibodies for contraception and for prophylaxis against sexually transmitted diseases. US006355235B1; 2002
  • McNatty KP, Hudson NI, Whiting L, The effects of immunizing sheep with different BMP15 or GDF9 peptide sequences on ovarian follicular activity and ovulation rate. Biol Reprod 2007;76:552-60
  • Luu KC, Nie GY, Salamonsen LA. Endometrial calbindins are critical for embryo implantation: evidence from in vivo use of morpholino antisense oligonucleotides. Proc Natl Acad Sci USA 2004;101:8028-33
  • White CA, Zhang JG, Salamonson LA, Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a non-hormonal contraceptive strategy. Proc Natl Acad Sci USA 2007;104:19357-62
  • Bohn H, Weinmann E. Immunological disruption of implantation in monkeys with antibodies to human pregnancy specific beta 1-glycoprotein (SP1). Arch Gynak 1974;17:209-18
  • Aitken RJ, Carey AJ, Beagley KW. Dual purpose contraceptives: targeting fertility and sexually transmitted disease. J Reprod Immunol 2011 [Epub ahead of print]
  • Sette A, Rapuolli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010;33:530-41
  • Zhang A, Li J, Zhao G, Intranasal co-administration with the mouse zona pellucida 3 expressing construct and its coding protein induces contraception in mice. Vaccine 2011. [Epub ahead of print]
  • Hu K, Dou J, Yu F, An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice. Vaccine 2011;29:1455-62
  • Czerkinsky C, Cuburu N, Kweon MN, Sublingual vaccination. Hum Vaccin 2011;7(1):110-14
  • Kirkpatrick JF, Lyda RO, Frank KM. Contraceptive Vaccines for Wildlife: a review. Am J Reprod Immunol 2011. [Epub ahead of print]
  • Mruk DD. New perspectives in non-hormonal male contraception. Trends Endocrinol Metab 2008;19:57-64

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.